Oncology trials - PowerPoint PPT Presentation


8th Next-Gen Immuno-Oncology Conference | 7th - 8th March 2024

Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of canc

0 views • 5 slides


Staff and Trials Overview at KVK Champhai, Mizoram

KVK Champhai, Mizoram, has a diverse staff including scientists and support staff. They conduct on-farm trials in disciplines like agronomy, horticulture, and plant protection. Trials aim to refine and assess technologies for crops like maize, beans, soybean, and more under various conditions. Speci

2 views • 49 slides



Infrastructure Trials for Technology Coordinators - Overview and Logistics

Explore the essential aspects of conducting infrastructure trials for technology coordinators in educational settings. The session covers topics such as determining the need for trials, tasks for technology staff, resources and support available, and live sandbox time for practical application. Pres

2 views • 58 slides


Understanding and Managing Burnout in Oncology Care: A Path to Better Well-being and Quality Care

In the field of oncology care, the importance of effective management to reduce burnout among healthcare providers is highlighted. Stress, psychosocial risks, and burnout definitions are explored, emphasizing the impact on healthcare professionals' well-being and job satisfaction. Studies reveal hig

2 views • 69 slides


Standing Firm in Fiery Trials: Lessons from Daniel 3

Embrace trials as part of your journey with Christ. Just like Daniel and his friends in Babylon, trust God to strengthen you through challenges. Trials refine and purify your faith, leading to genuine trust in the Lord's goodness. Turn to Him for hope and blessings in the midst of difficulties.

0 views • 14 slides


Next-Gen Immuno-Oncology Conference |20th - 21st June 2024| USA

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. \n\nRegister Now @ \/\/events.marketsandmarkets.com\/immuno-on

1 views • 6 slides


Market Trials Planning Overview

Market Trials Planning Overview provides a detailed timeline and procedures for the upcoming trials in the RTC+B program, including activities such as QSE Attestation, Market Submission Testing Objectives, and Transition to Go-Live. The document outlines potential dates, testing requirements, and ke

0 views • 12 slides


Understanding Trials and Persecution in the Christian Life

Embracing the challenges of difficult times as an inevitable part of the Christian journey, the Bible study delves into the concept of trials and suffering, drawing parallels to the process of an oyster creating a pearl. Through scriptural insights and reflections, it explores how trials strengthen

0 views • 15 slides


Ethical Issues in Clinical Pharmacy Research by Dr. Haider Raheem Mohammad

Research ethics play a crucial role in clinical trials and therapeutic research in the field of pharmacy. From discovery to validation, all medicines undergo rigorous evaluation processes to ensure safety, efficacy, and freedom from adverse effects. Clinical trials in both animals and humans are ess

0 views • 20 slides


Understanding Participant Rights, Responsibilities, and the Role of Patient Organisations in Clinical Trials

Participants in clinical trials have specific rights that are protected by law, including the right to informed consent and the right to be informed of any new benefits, risks, or side effects discovered during a study. They also have responsibilities such as adhering to the prescribed medication sc

0 views • 8 slides


Basics of Medical Terminology in Health Care Oncology

This module provides training on medical terminology basics for patient navigators in oncology. It covers defining terms using prefixes, root words, and suffixes, common oncology words, and available resources. Learn how to approach medical terminology effectively by understanding word roots and com

0 views • 20 slides


Understanding Ethics in Clinical Trials: A Comprehensive Overview

Explore the historical context, important ethical guidelines, and the ethical framework with 7 principles in the field of clinical trials. Learn about key trials, ethical considerations, and guidelines governing human subject research in clinical medicine. Delve into the critical aspects such as inf

1 views • 15 slides


Unified Stata Package for Sample Size Calculations in Clinical Trials

A comprehensive overview of artbin, a Stata package for determining sample sizes in trials with binary outcomes. This tool is essential for designing effective clinical trials across various disciplines and has recently undergone significant enhancements. Unlike other software, artbin offers a wide

1 views • 23 slides


Understanding Estimands in Oncology Clinical Trials

The concept of estimands in oncology clinical trials plays a crucial role in defining treatment effects and analyzing overall survival outcomes. This framework aims to enhance transparency, align trial objectives, and strengthen interdisciplinary dialogues. Introduced by the ICH E9(R1) guideline in

0 views • 14 slides


Ensuring Protocol Compliance and Corrective Action Plans in Clinical Trials

This content discusses the importance of creating Corrective Action and Preventive Action (CAPA) plans for protocol deviations in clinical trials. It covers the components of a CAPA, best practices for creating CAPAs for different deviation types, and regulatory compliance requirements according to

0 views • 33 slides


Understanding Essential Documents in Clinical Trials

This presentation by Derita Bran, BSN, RN, CCRC, focuses on the documentation required for quality clinical trials, emphasizing Essential Documents outlined in the ICH GCP E6 (R2) guidance. It covers the purpose, definition, and importance of these documents in ensuring subject rights protection, da

3 views • 35 slides


Understanding Investigational Products in Clinical Trials

Investigational products play a crucial role in clinical trials, encompassing drugs, devices, biologics, and more. The FDA defines investigational new drugs as substances seeking approval, even if previously in use, with potential changes. Similarly, investigational devices are those under investiga

0 views • 43 slides


Understanding Clinical Trials: Types and Designs

Clinical trials are essential research studies that evaluate new tests and treatments to improve human health outcomes. They involve various phases, designs, and purposes, such as treatment trials, prevention trials, and observational studies. Different types of clinical trial designs include experi

7 views • 18 slides


Veterinary Medicinal Products Clinical Trials in Ireland

This presentation covers the process and regulations surrounding clinical trials and testing of veterinary medicinal products in Ireland. Topics include the application process, HPRA evaluation, fees, scope of legislation, and the purpose of clinical trials. Feedback from a 2016 HPRA survey on clini

3 views • 17 slides


West Midlands Acute Oncology Directory of Services - Hospital Contact Information

This document lists contact information for various hospitals in the West Midlands area related to acute oncology services, including details of 24-hour advice lines, oncology nurses, consultants, and specific cancer service leads. Updates and changes to the information should be notified via email

0 views • 17 slides


Bayesian Approach in Pediatric Cancer Clinical Trials

Pediatric cancer clinical trials benefit from Bayesian analysis, allowing for the incorporation of uncertainty in prior knowledge and ensuring more informed decision-making. The use of Bayesian methods in the development of cancer drugs for children and adolescents, as emphasized by initiatives like

0 views • 26 slides


Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST3) Trials Overview

Overview of the BOOST3 trials focusing on brain oxygen optimization in severe traumatic brain injury patients. The trials involve multiple PIs, training sessions, and hands-on ancillary studies. Various design principles and organizational values are emphasized, with grant awards distributed to diff

0 views • 13 slides


Emerging Trends in Clinical Trial Designs for Oncology Drug Development

Master protocols, seamless trials, and adaptive designs are revolutionizing oncology drug development. These innovative approaches involve multiple substudies with different objectives, evaluating investigational drugs across disease subtypes. Basket trials and umbrella trials offer flexibility in s

0 views • 13 slides


Enhancing Patient Engagement in Clinical Trials

This presentation highlights the importance of patient engagement in clinical trials, showcasing the value it brings to the drug development process. It covers various aspects such as quantifying impact, identifying opportunities, and the role of patient groups. The Clinical Trials Transformation In

0 views • 37 slides


Insights into the Salem Witch Trials

Discover the dark history of the Salem Witch Trials, where people were accused of witchcraft based on superstitions and fear. Learn about the beliefs, trials, possible explanations, options for the accused, and the chaos that ensued in Salem. The trials lasted from January 1692 to May 1693, revealin

0 views • 11 slides


Challenges and Recommendations for DHT-derived Endpoints in Clinical Trials

This study by CTTI explores barriers and solutions for adopting digitally derived endpoints in clinical trials. Through in-depth interviews with industry sponsors, the research identifies gaps, barriers, and recommendations for using DHT-derived novel endpoints as key endpoints in pivotal clinical t

0 views • 16 slides


Evolution of Oncology Drug Development Strategies

Explore the shifting trends in oncology drug development, from understanding cancer mechanisms to new immuno-oncology approaches. Delve into the role of statisticians in researching cancer drugs and uncover the importance of early-phase trials in validating treatment mechanisms. Discover the need fo

0 views • 22 slides


Precision Oncology and Genomic Changes in Cancer Treatment

Explore the intricate details of cancer treatment through precision oncology, focusing on cell of origin, genomic changes, tumor microenvironment, host factors, and response to various treatments such as chemotherapy, biological therapy, and immune therapy. The natural history and histology-guided c

0 views • 9 slides


Insights into the Salem Witch Trials

Explore the historical beliefs around witchcraft, the occurrences of the Salem witch trials, possible explanations for the trials, the options accused witches had, how events quickly spiraled out of control in Salem, and the duration of the trials from January 1692 to May 1693.

0 views • 10 slides


Patient Feedback Summary for Neuro-Oncology Services at Bristol Haematology Oncology Centre

Patient feedback for the Neuro-Oncology services at Bristol Haematology Oncology Centre reflects a consistently positive experience. Patients found the staff to be supportive, informative, attentive, caring, and empathetic. The professionalism, humanism, kindness, and generosity of the oncology team

0 views • 9 slides


Advanced Moisture Renewal Mask for Oncology Spa Services

Bel Mondo Beauty introduces a breakthrough Moisture Renewal Mask made from bio cellulose, a fabric with incredible skin affinity and efficient ingredient transfer. This professional series mask targets oncology spa services, developed in collaboration with Oncology Spa Solutions to care for clients

0 views • 19 slides


Optimal Basket Designs for Efficacy Screening with Cherry-Picking

Efficacy screening in oncology trials involves evaluating multiple tumor types simultaneously to enhance drug development efficiency. Basket trials minimize missed opportunities but risk cherry-picking for positive results. Statistical methods, like multiplicity control and Bayesian information borr

0 views • 19 slides


Embracing Trials: A Biblical Perspective on Enduring Hardships

Understanding the role of trials in a Christian's life through the teachings of Peter. Be prepared to face trials, rejoice in Christ's sufferings, and never be ashamed of your faith amidst hardships. Others face trials too, so be encouraged and remain faithful.

0 views • 12 slides


Key Aspects of Partnering with a Clinical Trial Unit for Successful Trials

Understanding the role and benefits of partnering with a Clinical Trial Unit (CTU) is essential for potential Chief Investigators. A CTU handles various aspects of trial coordination, from developing trial materials to overseeing regulatory permissions and data management. UK Clinical Trials Units (

0 views • 48 slides


Statistical Issues in Clinical Trials: Insights from 13th Annual Conference

The 13th annual conference on Statistical Issues in Clinical Trials covered topics such as penalties for extra variation and limited degrees of freedom, the Diet-Heart Hypothesis, controlled trials, unit of randomization, and causal inference. Speakers highlighted the importance of addressing cluste

0 views • 10 slides


Challenges in Oncology Clinical Trials: Balancing Surgical and Radiation Therapies

Comparison between sublobar resection and stereotactic ablative radiotherapy (SAbR) in high-risk patients with stage I non-small cell lung cancer has faced challenges like poor accrual, equipoise concerns among surgeons, and complex eligibility criteria. Traditional phase III trials struggle due to

0 views • 35 slides


Introduction to Clinical Trials and Important Terms

This content provides an overview of clinical trials, including the goals, phases, study funding, and important terms such as placebo. Clinical trials aim to study the impacts of health and disease, evaluate treatments, and ensure safety and effectiveness. The phases of clinical trials are explained

0 views • 27 slides


Therapeutic Trials in HIV/HCV Coinfection: ION-4, Ally-2, and Viroteam 2015

In the study of therapeutic trials in HIV/HCV coinfection between 2014-2015, notable trials included ION-4 with LDV/SOF treatment for 12 weeks in HCV/HIV co-infection patients, showing high SVR rates in both treatment-naive and experienced patients. Another trial, Ally-2, involved Daclatasvir and So

0 views • 15 slides


NHMRC's New Grant Program: Advancing Clinical Trials and Research Funding

The NHMRC's latest grant program aims to enhance research in healthcare by focusing on clinical trials funding across four key streams: Investigator Grants, Synergy Grants, Ideas Grants, and Strategic and Leveraging Grants. The redistribution of funding will see a significant increase in support for

0 views • 12 slides


Phase II Trial Design in Oncology Drug Development by Wendy R. Parulekar, MD, FRCP

This presentation covers the pivotal role of Phase II trials in oncology drug development, emphasizing the importance of preliminary clinical efficacy screening, adverse event profiling, mechanism of action understanding, and target population definition. It discusses various Phase II trial designs,

0 views • 76 slides